Taro Pharmaceutical Industries TAROF
-
UPDATE 1-India's Sun Pharma Q3 net nearly doubles
MUMBAI, Feb 13 (Reuters) - Sun Pharmaceutical Industries Ltd, India's top drugmaker by market capitalisation, reported a better-than-expected 91 percent rise in December quarter net profit on robust sales by Israeli unit Taro Pharmaceutical Industries .
-
India Markets Monday Wrap-Up: Sensex's Negative Trend Continues
Equitymaster submits: Although the benchmark indices came off the day's lows during the closing hours, they still ended the day in the red. This is continuing with the negative trend seen last week. The BSE-Sensex closed lower by around 68 points (0.4%) whereas the NSE-Nifty had a better outing and
-
Dropping Coverage of Taro Pharma
We're dropping coverage of Taro Pharmaceutical Industries TAROF in order to focus on other investment opportunities in the health-care sector. Taro earned the lowest stewardship rating we …
-
Suspending Taro's Rating
We're suspending our rating for Taro Pharmaceutical Industries TAROF . The company has not filed Securities and Exchange Commission disclosures, including audited financial statements, since 2005 …
-
Taro under Review
We're placing Taro Pharmaceutical Industries TAROF under review following the termination of its merger agreement with Sun Pharmaceutical. We'll probably raise our fair value …
-
Taro Still Waiting for Votes
It appears Taro Pharmaceutical Industries TAROF still lacks the necessary votes to close its acquisition by India-based Sun Pharma. Last February, Sun Pharma paid $10.25 …
-
Taro Releases 2007 Results
Taro Pharmaceutical Industries TAROF released its preliminary financial statements for 2007 on Tuesday. We're maintaining our fair value estimate, as the results …
-
Taro Releases Unaudited Results
Taro Pharmaceutical Industries TAROF released Dec. 6 unaudited financial statements for the seven quarters ended Sept. 30, 2007. The results were poor, making …
-
Taro Margin Likely Deteriorates
Taro Pharmaceutical Industries TAROF has likely seen its gross margin deteriorate during the past two months given the rapid appreciation of the Canadian dollar. This …
-
Taro Stalls Vote Again
Taro Pharmaceutical Industries TAROF unveiled plans Thursday to delay, for the second time, its shareholder vote to approve the pending merger with Sun Pharmaceutical …